You need to enable JavaScript to run this web app.
Immunotherapy in Myeloma
Immunotherapy in multiple myeloma, first investigated with allogeneic stem cell transplantation, is now a major pillar in the treatment of multiple myeloma. CAR-T-cell technology, monoclonal or bispecific antibodies, as well as new forms of cellular therapy, have revolutionized the treatment of this hematological malignancy.

× Full-Screen Image < >
Der er i øjeblikket ingen priser på dette produkt.
Se evt historiske priser under Prisudvikling.
-- Beklager, Historiske data er i øjeblikket ikke tilgængelige --
Reload:N, Cached:Y (1505 sec left)
Page generated in 2.3420 msec.
online database: main